Kura Oncology
KURA
162 hedge funds and large institutions have $1.65B invested in Kura Oncology in 2020 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 42 increasing their positions, 54 reducing their positions, and 13 closing their positions.
736% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $1.71M
215% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 13
93% more capital invested
Capital invested by funds: $856M → $1.65B (+$793M)
21% more funds holding
Funds holding: 134 → 162 (+28)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.53% less ownership
Funds ownership: 96.16% → 95.62% (-0.53%)
22% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$30.6M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$25.4M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$12.1M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$11M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$8.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$28.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.7M |
| 3 |
PM
Prosight Management
Dallas,
Texas
|
-$12.8M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$11.1M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$10.1M |
KURA Hedge Fund Activity: Q3 2020 in Review
162 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2020, worth a combined $1.65B — up 93% from $856M a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new KURA positions and 13 closed out — a net gain of 28 holders — while 42 added to existing stakes and 54 trimmed.
The largest buyer was Avoro Capital Advisors, adding an estimated $30.6M. The largest seller was BVF Inc, cutting an estimated $28.4M.
- 162 institutional investors held Kura Oncology (KURA) as of Q3 2020, up from 134 in Q2 2020.
- Funds reported $1.65B of Kura Oncology stock for Q3 2020, up 93% quarter-over-quarter.
- 41 funds opened new Kura Oncology positions in Q3 2020 and 13 closed out, a net change of +28 holders.
- The largest Kura Oncology buyer in Q3 2020 was Avoro Capital Advisors, an estimated $30.6M added.
- The largest Kura Oncology seller in Q3 2020 was BVF Inc, an estimated $28.4M sold.
Based on aggregated 13F filings for Q3 2020.